Christoforos Hadjichrysanthou

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Preventing SARS-CoV-2 superspreading events with antiviral intranasal sprays.

Preventing SARS-CoV-2 superspreading events with antiviral intranasal sprays.

Journal: Journal of theoretical biology

Published: January 27, 2025

The impact of contact-network structure on important epidemiological quantities of infectious disease transmission and the identification of the extremes.

The impact of contact-network structure on important epidemiological quantities of infectious disease transmission and the identification of the extremes.

Journal: Journal of theoretical biology

Published: March 12, 2024

A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.

A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.

Journal: Scientific reports

Published: November 26, 2023

SARS-CoV-2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy.

SARS-CoV-2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy.

Journal: CPT: pharmacometrics & systems pharmacology

Published: April 14, 2023

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.

Journal: European journal of epidemiology

Published: October 07, 2022

Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community.

Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community.

Journal: Infectious diseases and therapy

Published: July 15, 2022

Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.

Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.

Journal: British journal of clinical pharmacology

Published: February 11, 2022

Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.

Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.

Journal: Scientific reports

Published: February 11, 2020

The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease.

The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: November 13, 2019

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets.

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: October 26, 2019

Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium.

Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium.

Journal: Neurology

Published: July 11, 2019

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 04, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026